Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
01 Agosto 2024 - 6:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2024
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
EXHIBIT INDEX
Exhibit Number
|
Description
|
99.1
|
1
August 2024 -
“Haleon 2024 Half Year Results”
|
|
|
99.1
Haleon plc: 2024 Half Year Results
1 August 2024: Haleon
plc (the "Company" or “Haleon”) (LSE/NYSE: HLN) today
announces its half year results for the year ended 31 December 2024
are available at: http://www.rns-pdf.londonstockexchange.com/rns/6703Y_1-2024-7-31.pdf
The half year results statement will also be available on the
Haleon website www.haleon.com/investors,
and the results have been submitted in full unedited text to the
Financial Conduct Authority's National Storage Mechanism and will
shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Consistent with our previous guidance to grow the dividend at least
in line with earnings, the Board has declared a H1 2024 interim
dividend of 2.0 pence per ordinary share, up 11% on the interim
dividend in 2023. This interim dividend is expected to be paid on
19 September 2024 to holders of ordinary shares and US American
Depositary Shares (“ADS”) on the register as of 16
August 2024 (the record date). The ex-dividend date is expected to
be 15 August 2024 for ordinary shareholders and 16 August 2024 for
holders of ADS. For ordinary shareholders wishing to participate in
the Dividend Reinvestment Programme (“DRIP”), the
election deadline for the DRIP is 30 August 2024.
As previously stated, subject to market conditions and Board
approval, Haleon expects to grow its ordinary dividend at least in
line with adjusted earnings.
Presentation for analysts and shareholders
A recorded results presentation by Brian McNamara, Chief Executive
Officer, and Tobias Hestler, Chief Financial Officer, will be
available shortly after 7:00am BST (8:00am CEST) on 1 August 2024
and can be accessed at www.haleon.com/investors. This will be followed by a Q&A session at
9:00am BST (10:00am CEST).
For
analysts and shareholders wishing to ask questions, please use the
dial-in details below which will have a Q&A
facility:
UK:
|
+44 (0)
800 358 1035
|
US:
|
+1 855
979 6654
|
All other:
|
+44 (0)
203 936 2999
|
Passcode:
|
646174
|
An
archived webcast of the Q&A call will be available later on the
day of the results and can be accessed at www.haleon.com/investors.
This information contains regulated information as per 6.3.7R of
the Disclosure and Transparency Rules of the Financial Conduct
Authority.
Amanda Mellor
Company Secretary
Enquiries
Investors
|
Media
|
Sonya Ghobrial
|
+44 7392 784784
|
Zoë Bird
|
+44 7736 746167
|
Rakesh Patel
|
+44 7552 484646
|
Gemma Thomas
|
+44
7985 175048
|
Emma White
|
+44 7823 523562
|
|
|
Email: investor-relations@haleon.com
|
Email: corporate.media@haleon.com
|
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with
a purpose to deliver better everyday health with humanity. Haleon's
product portfolio spans five major categories - Oral Health, Pain
Relief, Respiratory Health, Digestive Health and Other, and
Vitamins, Minerals and Supplements (VMS). Its long-standing brands
- such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin,
Polident, parodontax and Centrum - are built on trusted science,
innovation and deep human understanding.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
HALEON PLC
(Registrant)
|
Date:
August 1, 2024
|
By:
|
/s/
Amanda Mellor
|
|
|
Name:
|
Amanda
Mellor
|
|
|
Title:
|
Company
Secretary
|
Haleon (PK) (USOTC:HLNCF)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
Haleon (PK) (USOTC:HLNCF)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024